Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review.
Publication
, Journal Article
Cannon, L; Dvergsten, J; Stingl, C
Published in: J Rheumatol
March 2020
Duke Scholars
Published In
J Rheumatol
DOI
EISSN
1499-2752
Publication Date
March 2020
Volume
47
Issue
3
Start / End Page
479
Location
Canada
Related Subject Headings
- Treatment Outcome
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, Promyelocytic, Acute
- Humans
- Female
- Dermatomyositis
- Child
- Arthritis & Rheumatology
- Adolescent
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Cannon, L., Dvergsten, J., & Stingl, C. (2020). Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review. J Rheumatol, 47(3), 479. https://doi.org/10.3899/jrheum.190929
Cannon, Laura, Jeffrey Dvergsten, and Cory Stingl. “Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review.” J Rheumatol 47, no. 3 (March 2020): 479. https://doi.org/10.3899/jrheum.190929.
Cannon L, Dvergsten J, Stingl C. Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review. J Rheumatol. 2020 Mar;47(3):479.
Cannon, Laura, et al. “Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review.” J Rheumatol, vol. 47, no. 3, Mar. 2020, p. 479. Pubmed, doi:10.3899/jrheum.190929.
Cannon L, Dvergsten J, Stingl C. Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review. J Rheumatol. 2020 Mar;47(3):479.
Published In
J Rheumatol
DOI
EISSN
1499-2752
Publication Date
March 2020
Volume
47
Issue
3
Start / End Page
479
Location
Canada
Related Subject Headings
- Treatment Outcome
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, Promyelocytic, Acute
- Humans
- Female
- Dermatomyositis
- Child
- Arthritis & Rheumatology
- Adolescent
- 3204 Immunology